These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 4152996)

  • 1. Pharmacology of a new beta-adrenoceptor blocking agent, The 15219.
    Caputi AP; Marmo E; Saini RK
    Res Commun Chem Pathol Pharmacol; 1972 Jul; 4(1):25-35. PubMed ID: 4152996
    [No Abstract]   [Full Text] [Related]  

  • 2. On the clinical pharmacology of talinolol, a new beta 1-adrenoceptor blocking agent.
    Haustein KO; Fiehring H; Oltmanns G; Femmer K
    Int J Clin Pharmacol Biopharm; 1979 Dec; 17(12):465-70. PubMed ID: 43294
    [No Abstract]   [Full Text] [Related]  

  • 3. New N-isopropyl and N-tert.-butyl-phenoxypropanolaminic derivatives having -adrenolytic, anti-arrhythmic and local anaesthetic activity.
    Marmo E; Caputi AP; Saini RK
    Arzneimittelforschung; 1972 Jul; 22(7):1109-17. PubMed ID: 4404342
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacological actions of 1-(o-methoxyphenoxy)3-isopropylamino-2-propanol hydrochloride (S-D-1601), a new beta-blocking agent.
    Ferrini R; Miragoli G; Croce G
    Arzneimittelforschung; 1970 Aug; 20(8):1074-9. PubMed ID: 4394830
    [No Abstract]   [Full Text] [Related]  

  • 5. Protection against isoprenaline induced myocardial necroses by beta-adrenergic blocking agents.
    Kulig A; Kostka-Trabka E; Gryglewski R
    Pol J Pharmacol Pharm; 1973; 25(1):85-90. PubMed ID: 4149575
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
    Tachikawa S; Takenaka T
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
    [No Abstract]   [Full Text] [Related]  

  • 7. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
    Noguchi Y; Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
    [No Abstract]   [Full Text] [Related]  

  • 8. Studies on local anaesthetic and antiarrhythmic actions of 1-isopropylamino-3-(4-indanoxy)-2-propanol HCI (USVC-6524), a new beta-adrenoceptor antagonist.
    Madan BR; Vyas DS
    Indian J Physiol Pharmacol; 1973; 17(3):227-34. PubMed ID: 4151008
    [No Abstract]   [Full Text] [Related]  

  • 9. Pharmacological properties of a new beta-blocking agent (1-isopropylamino-3-(2-methyl-3-nitrophenoxy)-propan-2-ol).
    Michalska Z; Robak J; Kostka-Trabka E; Grodzińska L; Górka Z; Gryglewski R
    Folia Biol (Krakow); 1974; 22(2):217-28. PubMed ID: 4151603
    [No Abstract]   [Full Text] [Related]  

  • 10. [Inhibition of adrenergic beta receptors by N,N'-bis-[3-(2'ethoxyphenoxy)-2-hydroxypropyl]-ethylenediamine (Falirytmin) as compared to propranolol].
    Mentz P; Bayer BL; Wartner U; Terhaag B; Förster W
    Pharmazie; 1976; 31(9):640-2. PubMed ID: 14343
    [No Abstract]   [Full Text] [Related]  

  • 11. Central actions of some beta-adrenoceptor blocking agents.
    Shah UH; Jindal MN; Patel VK; Kelkar VV
    Arzneimittelforschung; 1974 Oct; 24(10):1581-4. PubMed ID: 4154760
    [No Abstract]   [Full Text] [Related]  

  • 12. Properties of 1-isopropylamino-3-(4-indanoxy)-2-propanol (USVC 6524), an adrenergic -receptor blocking agent.
    Marmo E; Saini RK; Caputi AP
    Farmaco Prat; 1972 Dec; 27(12):661-87. PubMed ID: 4405106
    [No Abstract]   [Full Text] [Related]  

  • 13. Cardiovascular beta-adrenergic receptor blocking activities of 1-(7-indenyloxy)-3-isopropyl-aminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H; Noguchi Y; Nakao K; Takagi K
    Jpn J Pharmacol; 1974 Apr; 24(2):261-70. PubMed ID: 4152803
    [No Abstract]   [Full Text] [Related]  

  • 14. [Experimental analysis of the cardiovascular effects of acebutolol, a drug with beta-adrenolytic activity].
    Marmo E; Rossi F; Lampa E; Chieppa S; Apolito A; Del Vecchio F
    Arch Sci Med (Torino); 1978; 135(1):57-78. PubMed ID: 25058
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological studies with 1-isopropylamino-3-(o-allyloxyphenoxy)-2-propanol-hydrochloride, an adrenergic beta-receptor blocking agent].
    Brunner H; Hedwall PR; Meier M
    Arzneimittelforschung; 1968 Feb; 18(2):164-70. PubMed ID: 5695373
    [No Abstract]   [Full Text] [Related]  

  • 16. Metabolic profile of beta-adrenoceptor-blocking action of befunolol.
    Maruyama Y; Awaji T; Inoue M; Takeo S
    Arch Int Pharmacodyn Ther; 1991; 311():73-88. PubMed ID: 1686392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. -adrenergic blocking and cardiovascular properties of a new compound, 1-(7-indenyloxy)-3-isopropylaminopropan-2-ol-hydrochloride (YB-2).
    Tanenaka T; Tachikawa S
    Arzneimittelforschung; 1972 Nov; 22(11):1864-9. PubMed ID: 4144713
    [No Abstract]   [Full Text] [Related]  

  • 18. beta-adrenoreceptor blocking and antihypertensive activity of PP-24, a newly synthesized aryloxypropanolamine derivative.
    Nikam AP; Bodhankar SL; Piplani P; Bansal J; Thakurdesai PA
    J Pharm Pharmacol; 2008 Nov; 60(11):1501-6. PubMed ID: 18957171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cardioactive and related properties of N-methyl-N-( -phenylethyl)-1,2,3,4-tetrahydro-6-methoxy-4,4-dimethyl-2-naphthylamine hydrochloride (2-AT-1).
    Graeff DM; Johnson WE; Martin AR
    Arch Int Pharmacodyn Ther; 1971 Sep; 193(1):134-48. PubMed ID: 4398737
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.